Improving pre-clinical experimental models to test anti cancer drugs
Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada
Improving pre-clinical experimental models to test anti cancer drugs ( Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada )
21 Jul 2011
Early stage molecular profiling
Prof Razelle Kurzrock - MD Anderson Cancer Centre, Houston, USA
Early stage molecular profiling ( Prof Razelle Kurzrock - MD Anderson Cancer Centre, Houston, USA )
19 Jul 2011
Emergence of ipilimumab and vemurafenib for melanoma
Prof Reinhard Dummer, Prof Claus Garbe, Dr Caroline Robert, Prof Jürgen Becker
Emergence of ipilimumab and vemurafenib for melanoma ( Prof Reinhard Dummer, Prof Claus Garbe, Dr Caroline Robert, Prof Jürgen Becker )
15 Jul 2011
The P-Medicine project; data sharing and integration for personalised medicine
Dr Simona Rossi - Swiss Institute for Bioinformatics, Lausanne, Switzerland
The P-Medicine project; data sharing and integration for personalised medicine ( Dr Simona Rossi - Swiss Institute for Bioinformatics, Lausanne, Switzerland )
14 Jul 2011
The changing landscape of melanoma therapies: indications of better patient outc...
Prof Alexander Eggermont, Dr Caroline Robert, Prof John Haanen and Prof Reinhard...
The changing landscape of melanoma therapies: indications of better patient outcome ( Prof Alexander Eggermont, Dr Caroline Robert, Prof John Haanen and Prof Reinhard Dummer )
24 Jun 2011
Role of vemurafenib in melanoma treatment
Dr Paul Nathan - Mount Vernon Cancer Centre - Northwood, UK
Role of vemurafenib in melanoma treatment ( Dr Paul Nathan - Mount Vernon Cancer Centre - Northwood, UK )
24 Jun 2011
Combining oral targeted therapies shows early anti-tumour activity for advanced ...
Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA
Combining oral targeted therapies shows early anti-tumour activity for advanced melanoma ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )
20 Jun 2011
Cancer prevention through education
Prof Angelo Paradiso - Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy
Cancer prevention through education ( Prof Angelo Paradiso - Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy )
17 Jun 2011
Highlights from 2011 and ASCO’s future
Prof George Sledge - Indiana University, USA
Highlights from 2011 and ASCO’s future ( Prof George Sledge - Indiana University, USA )
17 Jun 2011
Ipilimumab improves survival in metastatic melanoma
Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Ipilimumab improves survival in metastatic melanoma ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
17 Jun 2011
New melanoma drug gives 63 percent reduction in risk of death compared to dacarb...
Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center
New melanoma drug gives 63 percent reduction in risk of death compared to dacarbazine ( Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center )
17 Jun 2011
ASCO 2011 highlights
Prof Gordon McVie – ecancer Managing Editor
ASCO 2011 highlights ( Prof Gordon McVie – ecancer Managing Editor )
16 Jun 2011